https://www.selleckchem.com/pr....oducts/abraxane-nab-
symptomatic carotid stenosis was associated with lower risk of stroke or death (3.0% vs 4.3%; RR 0.69 [95%CI 0.47-0.998]; P = .048), whereas there were no statistically significant differences in stroke or death with protamine use in asymptomatic patients (1.6% vs 1.0%; RR 1.63 [95%CI 0.67-3.92]; P = .28). Conclusions Heparin-reversal with protamine following transfemoral carotid artery stenting is not associated with an increased risk of thromboembolic events and its use in symptomatic carotid disease is associated with
Like
Comment
Share
